These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16634988

  • 1. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder.
    Bauer C, Fischer A, Keller U.
    Diabetes Obes Metab; 2006 May; 8(3):289-95. PubMed ID: 16634988
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, Zanella MT, Coutinho W.
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [Abstract] [Full Text] [Related]

  • 3. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
    Hainer V, Kunesova M, Bellisle F, Hill M, Braunerova R, Wagenknecht M.
    Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
    [Abstract] [Full Text] [Related]

  • 4. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
    Mitchell JE, Gosnell BA, Roerig JL, de Zwaan M, Wonderlich SA, Crosby RD, Burgard MA, Wambach BN.
    Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
    [Abstract] [Full Text] [Related]

  • 5. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
    Devlin MJ, Goldfein JA, Petkova E, Jiang H, Raizman PS, Wolk S, Mayer L, Carino J, Bellace D, Kamenetz C, Dobrow I, Walsh BT.
    Obes Res; 2005 Jun; 13(6):1077-88. PubMed ID: 15976151
    [Abstract] [Full Text] [Related]

  • 6. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [Abstract] [Full Text] [Related]

  • 7. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K, Finer N, Rössner S.
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [Abstract] [Full Text] [Related]

  • 8. Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial.
    Grilo CM, Masheb RM, Salant SL.
    Biol Psychiatry; 2005 May 15; 57(10):1193-201. PubMed ID: 15866560
    [Abstract] [Full Text] [Related]

  • 9. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM, Balance Study Group.
    Eur J Clin Nutr; 2005 Aug 15; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [Abstract] [Full Text] [Related]

  • 10. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL, Apovian CM, Aronne LJ, Fernstrom MH, Frank A, Greenway FL, Heber D, Kushner RF, Cwik KM, Walch JK, Hewkin AC, Blakesley V.
    Obesity (Silver Spring); 2007 Jun 15; 15(6):1464-72. PubMed ID: 17557984
    [Abstract] [Full Text] [Related]

  • 11. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio Paparatti U, Pasanisi F.
    Nutr Metab Cardiovasc Dis; 2005 Feb 15; 15(1):24-30. PubMed ID: 15871847
    [Abstract] [Full Text] [Related]

  • 12. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
    Di Francesco V, Sacco T, Zamboni M, Bissoli L, Zoico E, Mazzali G, Minniti A, Salanitri T, Cancelli F, Bosello O.
    Ann Nutr Metab; 2007 Feb 15; 51(1):75-81. PubMed ID: 17356258
    [Abstract] [Full Text] [Related]

  • 13. Influence of weight reduction by sibutramine on female sexual function.
    Kim KK, Kang HC, Kim SS, Youn BB.
    Int J Obes (Lond); 2006 May 15; 30(5):758-63. PubMed ID: 16404407
    [Abstract] [Full Text] [Related]

  • 14. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr 15; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 15. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
    Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR.
    Clin Gastroenterol Hepatol; 2007 Jul 15; 5(7):829-37. PubMed ID: 17544870
    [Abstract] [Full Text] [Related]

  • 16. Impact of weight loss on the metabolic syndrome.
    Phelan S, Wadden TA, Berkowitz RI, Sarwer DB, Womble LG, Cato RK, Rothman R.
    Int J Obes (Lond); 2007 Sep 15; 31(9):1442-8. PubMed ID: 17356528
    [Abstract] [Full Text] [Related]

  • 17. Orlistat and sibutramine beyond weight loss.
    Mannucci E, Dicembrini I, Rotella F, Rotella CM.
    Nutr Metab Cardiovasc Dis; 2008 Jun 15; 18(5):342-8. PubMed ID: 17928208
    [Abstract] [Full Text] [Related]

  • 18. Treatment preferences of patients with binge eating disorder.
    Brody ML, Masheb RM, Grilo CM.
    Int J Eat Disord; 2005 May 15; 37(4):352-6. PubMed ID: 15856505
    [Abstract] [Full Text] [Related]

  • 19. Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo.
    Samsa GP, Kolotkin RL, Williams GR, Nguyen MH, Mendel CM.
    Am J Manag Care; 2001 Sep 15; 7(9):875-83. PubMed ID: 11570021
    [Abstract] [Full Text] [Related]

  • 20. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N, Ryan DH, Renz CL, Hewkin AC.
    Diabetes Obes Metab; 2006 Mar 15; 8(2):206-13. PubMed ID: 16448525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.